ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1764

The Utility of Serum Angiopoietin-1 and Angiopoietin-2 in Patients with Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis

Yoko Wada1, Takeshi Kuroda2, Masaaki Nakano3 and Ichiei Narita1, 1Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan, 2Health Administration Center, Niigata University, Niigata, Japan, 3Department of Medical Technology, School of Health Sciences, Faculty of Medicine, Niigata University, Niigata, Japan

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: ANCA, angiopoietin, biomarkers and vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Title: Vasculitis – ANCA-Associated Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Angiopoietin-1 (Ang-1) and Angiopoietin-2 (Ang-2) are antagonistic ligands which bind with similar affinity to the extracellular domain of the tyrosine kinase with Ig-like and epidermal growth factor-like domains 2 (Tie-2) receptor, which is almost exclusively expressed by endothelial cells. Ang-1/Tie-2 signalling maintains vessel integrity, inhibits vascular leakage, suppresses inflammatory gene expression and prevents recruitment and transmigration of leukocytes. In contrast, binding of Ang-2 disrupts protective Ang-1/Tie-2 signalling and facilitates endothelial inflammation. The purpose of this study is to examine the serum Angpt1 and Angpt2 levels in patients with AAV, and explore the utility as biomarkers.

Methods: Seventy-one patients who had been diagnosed as AAV and referred to Niigata University Medical and Dental Hospital between 2009 and 2017, were participated in this study. Serum Ang-1 and Ang-2 levels were measured by enzyme-linked immunosorbent assay, before the initiation of remission-induction therapy. Laboratory findings, disease activity using Birmingham vasculitis activity score (BVAS) at the time of diagnosis, and patients’ kidney and overall prognosis at August 2017, were corrected from patients’ clinical records. The correlations between these findings and serum Ang-1, Ang-2 levels, and Ang-1/Ang-2 ratio were analyzed by Spearman correlation coefficient and stepwise multiple regression analysis. A value of p <0.05 was taken to indicate statistical significance.

Results: In Spearman correlation coefficient analysis, serum Ang-1 was positively correlated with estimated glomerular filtration ratio (eGFR) (r=0.3979、p=0.0006) and C-reactive protein (0.2574, p=0.0302), and negatively correlated with serum creatinine (Cr) (r=-0.3438、p=0.0033), initiation of dialysis therapy (r=-0.2559, p=0.0312), and death (r=-03057, p=0.0095). Serum Ang-2 was positively correlated with age (r=0.2466, p=0.0382), BVAS (r=0.3090、p=0.0087), serum Cr (r=0.3945、p=0.0007), and negatively correlated with eGFR (r=-0.4278、p=0.0002). The Ang-1/Ang-2 ratio was positively correlated with eGFR(r=0.5715、p<0.0001), and negatively correlated with age (r=-0.2359, p=0.0476), BVAS (r=-0.3456, p=0.0032), Cr (r=-0.5234), 24-hour urinary protein excretion (r=-0.2863, p=0.0155), initiation of dialysis therapy (r=-0.3251, p=0.0057), and death (r=-0.2556, p=0.0314). In stepwise multiple regression analysis, eGFR was selected as a positive independent variable for serum Ang-1 levels (beta=0.4138, p=0.0003) and Ang-1/ Ang-2 ratio (beta=0.4305, p=0.00017), whereas initiation of dialysis therapy was selected as a positive independent variable (beta=0.2803, p=0.033), and UP/Cr (beta=-0.3908, p=0.0043) and eGFR (beta=-0.4897, p=0.0001) were selected as negative independent variables for serum Ang-2 levels.

Conclusion: These findings showed the protective effect of kidney functions for Ang-1 and the utility of Ang-2 as a predictive factor for kidney prognosis.


Disclosure: Y. Wada, None; T. Kuroda, None; M. Nakano, None; I. Narita, None.

To cite this abstract in AMA style:

Wada Y, Kuroda T, Nakano M, Narita I. The Utility of Serum Angiopoietin-1 and Angiopoietin-2 in Patients with Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/the-utility-of-serum-angiopoietin-1-and-angiopoietin-2-in-patients-with-anti-neutrophil-cytoplasmic-autoantibody-associated-vasculitis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-utility-of-serum-angiopoietin-1-and-angiopoietin-2-in-patients-with-anti-neutrophil-cytoplasmic-autoantibody-associated-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology